PROSPECTUS SUPPLEMENT                          Filed pursuant to Rule 424(b)(3)
to Prospectus dated August 2, 2000                   Registration No. 333-36318

                                  $200,000,000

                             INCYTE GENOMICS, INC.

                  5.5% CONVERTIBLE SUBORDINATED NOTES DUE 2007
                                      and
                             SHARES OF COMMON STOCK
                     ISSUABLE UPON CONVERSION OF THE NOTES

     This prospectus supplement relates to the resale by the holders of 5.5%
convertible subordinated notes due 2007 of Incyte Genomics, Inc. and the shares
of common stock issuable upon conversion of the notes.

     This prospectus supplement should be read in conjunction with the
prospectus dated August 2, 2000, which is to be delivered with this prospectus
supplement.

     The information in the table appearing under the heading "Selling
Securityholders" in the prospectus is supplemented and superseded in part by
the information appearing in the table below:




                                                 Principal Amount                                                Common Stock
                                                     of Notes             Common Stock                            Owned After
                                                   Beneficially          Issuable Upon                            Completion
                                                    Owned and              Conversion         Common Stock          of the
                      Name                          Offered(1)          of the Notes(1)        Offered(1)         Offering(1)
                      ----                       ----------------       ---------------       ------------       ------------
                                                                                                          
Argent Classic Convertible Arbitrage Fund
      (Bermuda) L.P............................    $8,000,000                59,330              59,330               -

Deutsche Bank Securities Inc..................    $10,073,000                74,703              74,703               -

McMahan Securities Co. L.P....................       $500,000                 3,708               3,708               -

Morgan Stanley & Co............................   $10,000,000                74,162              74,162               -



                                  ------------

(1)      Amounts indicated may be in excess of the total amount registered due
         to sales or transactions exempt from the registration requirements of
         the Securities Act of 1933 since the date on which selling
         securityholders provided information to us regarding their notes.

         None of the selling securityholders listed above nor any of their
         affiliates, officers, directors or principal equity holders has held
         any position or office or has had any material relationship with us
         within the past three years.

                              --------------------

     Investing in the notes and our common stock involves a high degree of
risk. You should carefully read and consider the "Risk Factors" beginning on
page 3 of the prospectus.

                              --------------------

    Neither the Securities and Exchange Commission nor any state securities
commission has approved or disapproved of these securities or passed upon the
accuracy or adequacy of this prospectus supplement or the prospectus. Any
representation to the contrary is a criminal offense.

                              --------------------


           The date of this Prospectus Supplement is August 18, 2000.